NYSE:ORN - Post Discussion
Post by
whytestocks on Jun 26, 2024 3:30pm
ORYZON Announces Presentation of Final Data From PORTICO, Va
Just In: $ORN ORYZON Announces Presentation of Final Data From PORTICO, Vafidemstat's Global Phase IIb Trial in Borderline Personality Disorder, at the 37th ECNP Annual ConferenceSelected for oral presentation Conference will be held in Milan on September 21-23 MADRID and CAMBRIDGE, Mass., June 26, 2024 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to develop th...
ORN - ORYZON Announces Presentation of Final Data From PORTICO, Vafidemstat's Global Phase IIb Trial in Borderline Personality Disorder, at the 37th ECNP Annual Conference
Be the first to comment on this post